Brooks Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE650L01011
  • NSEID: BROOKS
  • BSEID: 533543
INR
99.45
-0.25 (-0.25%)
BSENSE

Dec 05

BSE+NSE Vol: 29.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
23.45
25.51
23.32
20.52
20.79
17.93
17.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
23.45
25.51
23.32
20.52
20.79
17.93
17.72
Raw Material Cost
10.42
13.62
13.68
12.17
11.40
9.80
9.74
Purchase of Finished goods
3.00
2.41
1.72
1.19
1.24
3.03
3.11
(Increase) / Decrease In Stocks
0.29
-0.13
0.41
-0.60
0.56
-0.52
-0.13
Employee Cost
3.93
3.67
3.38
3.29
3.21
3.07
2.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
3.29
2.83
2.58
2.89
2.87
2.27
2.34
Total Expenditure (Excl Depreciation)
20.93
22.39
21.77
18.94
19.28
17.65
17.34
Operating Profit (PBDIT) excl Other Income
2.52
3.12
1.55
1.58
1.51
0.28
0.38
Other Income
0.39
0.22
0.62
0.03
0.20
0.07
0.65
Operating Profit (PBDIT)
2.91
3.34
2.17
1.61
1.71
0.35
1.03
Interest
0.28
0.30
0.26
0.28
0.32
0.16
0.27
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2.63
3.04
1.91
1.33
1.39
0.19
0.76
Depreciation
0.39
0.39
0.39
0.38
0.43
0.40
0.46
Profit Before Tax
7.98
9.58
-1.28
-2.13
-3.96
-2.41
-9.61
Tax
0.00
0.00
0.18
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2.24
2.65
1.34
0.94
0.96
-0.21
0.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2.24
2.65
1.34
0.94
0.96
-0.21
0.30
Share in Profit of Associates
5.74
6.93
-2.80
-3.07
-4.92
-2.20
-9.91
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
7.98
9.58
-1.46
-2.13
-3.96
-2.41
-9.61
Equity Capital
29.46
29.46
29.46
26.25
26.25
26.25
26.25
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
49.25
Earnings per share (EPS)
2.71
3.25
-0.5
-0.81
-1.51
-0.92
-3.66
Diluted Earnings per share
2.71
3.25
-0.54
-1.75
-1.51
-0.94
-3.77
Operating Profit Margin (Excl OI)
10.75%
12.23%
6.65%
7.7%
7.26%
1.56%
2.14%
Gross Profit Margin
11.22%
11.92%
8.19%
6.48%
6.69%
1.06%
4.29%
PAT Margin
34.03%
37.55%
-6.26%
-10.38%
-19.05%
-13.44%
-54.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -8.08% vs 9.39% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -16.70% vs 756.16% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -19.23% vs 101.29% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -6.67% vs 15.38% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Brooks Lab. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
23.45
36.66
-13.21
-36.03%
Other Operating Income
0.00
0.00
0.00
Total Operating income
23.45
36.66
-13.21
-36.03%
Raw Material Cost
10.42
8.97
1.45
16.16%
Purchase of Finished goods
3.00
5.67
-2.67
-47.09%
(Increase) / Decrease In Stocks
0.29
0.23
0.06
26.09%
Employee Cost
3.93
10.40
-6.47
-62.21%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
3.29
13.92
-10.63
-76.36%
Total Expenditure (Excl Depreciation)
20.93
39.20
-18.27
-46.61%
Operating Profit (PBDIT) excl Other Income
2.52
-2.54
5.06
199.21%
Other Income
0.39
1.09
-0.70
-64.22%
Operating Profit (PBDIT)
2.91
-1.45
4.36
300.69%
Interest
0.28
0.79
-0.51
-64.56%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
2.63
-2.24
4.87
217.41%
Depreciation
0.39
2.15
-1.76
-81.86%
Profit Before Tax
7.98
-4.38
12.36
282.19%
Tax
0.00
-1.17
1.17
100.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
2.24
-3.21
5.45
169.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
2.24
-3.21
5.45
169.78%
Share in Profit of Associates
5.74
0.00
5.74
Minority Interest
0.00
0.14
-0.14
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7.98
-3.36
11.34
337.50%
Equity Capital
29.46
35.69
-6.23
-17.46%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.71
-0.94
3.65
388.30%
Diluted Earnings per share
2.71
-0.94
3.65
388.30%
Operating Profit Margin (Excl OI)
10.75%
-6.93%
0.00
17.68%
Gross Profit Margin
11.22%
-6.11%
0.00
17.33%
PAT Margin
34.03%
-8.76%
0.00
42.79%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 23.45 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -8.08% vs 9.39% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 12.79% vs -14.51% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 7.98 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -16.70% vs 756.16% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 301.52% vs -141.46% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.52 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -19.23% vs 101.29% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 66.89% vs -12.21% in Sep 2024

Quarterly - Interest
Interest 0.28 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -6.67% vs 15.38% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -12.50% vs 68.42% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.75%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024